… COVID-19 complications. The following inflammatory, biochemical, and hematology biomarkers
markers have been identified in COVID-19 … in the pathogenesis of COVID-19. CRP is an …

… COVID‐19 complications, we suggest using this potential clinical biomarker or any of the
above laboratory markers as a guide to monitor patients on drug therapy. COVID‐19 treatment …

… (CT) during the first week of COVID-19 infection; however, these observations did not report
… state of knowledge regarding known biomarkers for COVID-19 infection, focusing on those …

… However, the clinical usefulness of these biomarkers in COVID-19 is far from proven. The …
of studies on biomarkers for the prognosis and treatment response in COVID-19 patients. We …

… the thrombotic signature of COVID-19 and present the latest biomarkers and platforms to …
In this section, we review the biomarkers that are relevant to thrombotic risk in COVID-19. …

… biomarkers to predict clinical outcome remains elusive. Here, we analyzed levels of 66
soluble biomarkers in 175 Italian patients with COVID-19 … potential biomarkers of COVID-19 …

… COVID-19 compared to historic controls. This study suggests ongoing peripheral and
neuroinflammation after COVID-19 … in this study was apparent in the 24 COVID-19 participants. …

… coronavirus disease 2019 (COVID-19) by exposure to the severe acute respiratory
syndrome-coronavirus-2 … 34% to 68% of COVID-19–positive patients. Otorhinolaryngology …

… Over 5,488,000 cases of coronavirus disease-19 (COVID-19) have been reported since …
with mortality in COVID-19 patients and assess the use of D-dimer as a biomarker for disease …

… use of biological markers (biomarkers). These provide objective … biomarkers in the disease
pathogenesis of COVID-19 and … The biomarkers we review include, C-reactive protein (CRP), …